Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge
- PMID: 32703822
- PMCID: PMC7376285
- DOI: 10.1183/13993003.01832-2020
Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge
Abstract
On recovery from COVID-19 it is important to draw attention to the CO diffusion test and the actual meaning of the findings when considering the values of DLCO and DLCO/VA put together
Conflict of interest statement
Conflict of interest: S. Nusair has nothing to disclose.
Comment in
-
Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients.Eur Respir J. 2021 Jan 28;57(1):2004265. doi: 10.1183/13993003.04265-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 33361097 Free PMC article.
Comment on
-
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.Eur Respir J. 2020 Jun 18;55(6):2001217. doi: 10.1183/13993003.01217-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32381497 Free PMC article.
References
-
- Spagnolo P, Balestro E, Aliberti S, et al. . Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir 2020; in press [https://doi.org/10.1016/S2213-2600(20)30222-8]. doi:10.1016/S2213-2600(20)30222-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources